Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) met Wall Streets revenue expectations in Q3 CY2025, with sales up 11% ...

Boston-based Vertex reported revenue of $3.08 billion, an 11 percent gain from one year ago. That was ahead of analysts’ ...

Q3 2025 Earnings Call Transcript November 3, 2025 Vertex, Inc. reports earnings inline with expectations. Reported EPS is ...

The potential approval of Vertex’s IgAN therapy povetacicept in 2026 comes amid launch headwinds for the company’s non-opioid ...

Vertex (VERX) shares have come under pressure in recent trading. The stock has seen losses of 7% over the past day and nearly 10% for the week. This has sparked questions about what might be driving ...

Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay ...

EXCLUSIVE: The Express has campaigned for cystic fibrosis sufferers for six years but now a charity is highlighting the CF ...

AI is revolutionizing how the Department of Homeland Security protects the U.S. via better border and airport security, as examples.

Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the ...

The brain drug developer plans to slash R&D expenses by about 60% in the wake of the FDA surprisingly rejecting its rare disease drug Vyglxia.

The 1925 Paris Expo established an audacious new design style of architecture, fashion and graphics. In the Watches & ...

Greenberg Traurig has confirmed that it has hired Baker McKenzie’s international capital markets Asia Pacific head and former ...